Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Cureus ; 15(5): e38743, 2023 May.
Article in English | MEDLINE | ID: mdl-37303348

ABSTRACT

Klebsiella pneumoniae is a known cause of pyogenic liver abscess and has an increased prevalence in Southeast Asia. We present two cases of individuals with remote travel history to southeast Asia presenting with fevers, chills, and abdominal pain secondary to pyogenic liver abscess. Neither individual had a comorbid medical condition or history of prior hepato-biliary pathology that would predispose them to bacterial translocation and abscess formation. These patients were both successfully treated with percutaneous drainage and antibiotics. We present these cases to add to the growing body of literature surrounding hyper-mucoid strains of Klebsiella pneumonia causing a pyogenic liver abscess.

2.
Cureus ; 14(4): e23745, 2022 Apr.
Article in English | MEDLINE | ID: mdl-35509737

ABSTRACT

Tissierella praeacuta is a gram negative anaerobe with few documented cases of human infections. This case illustrates a patient who was admitted for infected chronic sacral and ischial decubitus wounds. BACT/ALERT blood culture system using Matrix Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) (Bruker Daltonics, Billerica, USA) was employed ultimately identifying Tissierella praeacuta as the causative organism. The suspected source of the pathogen was presumed to be from his infected decubitus wounds.

3.
Am J Surg ; 220(1): 203-207, 2020 07.
Article in English | MEDLINE | ID: mdl-31668774

ABSTRACT

BACKGROUND: Remote appendectomy was linked to increased incidence of Clostridioides difficile infection (CDI). We evaluated the effect of absence of vermiform appendix and/or gallbladder on recurrence rate and severity of CDI. METHODS: We assessed a systemwide patient cohort diagnosed with initial CDI in 2014 (n = 250). The primary outcome was recurrence. RESULTS: Appendix and gallbladder were absent among 47 and 64 patients, respectively. CDI recurrence rate was similar among patients without and with appendix (24/47, 51.1% versus 90/203 patients, 44.3%; p = 0.404) and similar among patients without and with gallbladder (29/64 patients, 45.3% versus 85/186 patients, 45.7%; p = 0.957). Mortality was similar between appendectomy versus appendix in situ patients (3/47, 6.4% versus 9/203, 4.4%; p = 0.573), but higher mortality rate was seen among those without gallbladder (7/64 patients with prior cholecystectomy, 10.9% versus 5/186 patients with intact gallbladder, 2.7%; p = 0.008). CONCLUSION: Clostridioides difficile recurrence rate is not affected by remote appendectomy or cholecystectomy. Patients with prior cholecystectomy experience higher mortality rates associated with their CDI.


Subject(s)
Appendectomy/adverse effects , Cholecystectomy/adverse effects , Clostridioides difficile/isolation & purification , Clostridium Infections/epidemiology , Cross Infection/epidemiology , Gallbladder Diseases/surgery , Aged , Cross Infection/microbiology , Female , Humans , Incidence , Male , Postoperative Period , Prognosis , Risk Factors , Survival Rate/trends , United States/epidemiology
4.
J Cardiometab Syndr ; 1(3): 209-14; quiz 215-6, 2006.
Article in English | MEDLINE | ID: mdl-17679819

ABSTRACT

The cardiometabolic syndrome is a state of metabolic and vascular dysregulation. The cardiometabolic syndrome is clinically composed of a cluster of metabolic abnormalities including insulin resistance/hyperinsulinemia, central/visceral obesity, dyslipidemia, hypertension, microalbuminuria, fibrinolytic and inflammatory abnormalities, endothelial dysfunction, oxidative stress, and hypercoagulability, which collectively lead to an increased risk of cardiovascular and renal outcomes. The development of microalbuminuria is now accepted as a marker of systemic endothelial dysfunction and, if it progresses to macroalbuminuria (i.e., >200 mg/d albuminuria), then kidney disease is evident. Collectively, visceral obesity, insulin resistance/hyperinsulinemia, and other components of the cardiometabolic syndrome lead to an increased risk of microalbuminuria and progressive loss of renal function. Hence, aggressive management of risk factors for the metabolic syndrome, nonpharmacologic and pharmacologic, is essential to prevent or delay the progressive loss of renal function and chronic kidney disease.


Subject(s)
Hyperinsulinism/complications , Insulin Resistance , Obesity/complications , Renal Insufficiency, Chronic/etiology , Albuminuria/etiology , Albuminuria/physiopathology , Humans , Hyperinsulinism/epidemiology , Hyperinsulinism/physiopathology , Obesity/epidemiology , Obesity/physiopathology , Renal Insufficiency, Chronic/complications , Renal Insufficiency, Chronic/epidemiology , Renal Insufficiency, Chronic/physiopathology , Risk Assessment , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...